These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 18973143

  • 21. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
    Chalise PR, Agrawal CS.
    Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, Reich O, Gasser TC, Bachmann A.
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The long-term results of transurethral vaporization of the prostate using plasmakinetic energy.
    Kaya C, Ilktac A, Gokmen E, Ozturk M, Karaman IM.
    BJU Int; 2007 Apr; 99(4):845-8. PubMed ID: 17378844
    [Abstract] [Full Text] [Related]

  • 27. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Huang T, Qi J, Yu YJ, Xu D, Jiao Y, Kang J, Chen YQ, Zhu YK.
    Int J Urol; 2012 Apr; 19(4):343-50. PubMed ID: 22220830
    [Abstract] [Full Text] [Related]

  • 28. [Value of transurethral resection of the prostate (TURP) for treatment of symptomatic benign prostatic obstruction (BPO): an analysis of efficiency and complications in 1015 cases].
    Zepnick H, Steinbach F, Schuster F.
    Aktuelle Urol; 2008 Sep; 39(5):369-72. PubMed ID: 18798126
    [Abstract] [Full Text] [Related]

  • 29. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
    Chughtai B, Dunphy C, Lee R, Lee D, Sheth S, Marks L, Kaplan SA, Te AE.
    Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
    [Abstract] [Full Text] [Related]

  • 30. TURP and low-energy TUMT treatment in men with LUTS suggestive of bladder outlet obstruction selected by means of pressure-flow studies: 8-year follow-up.
    Vesely S, Knutson T, Damber JE, Dicuio M, Dahlstrand C.
    Neurourol Urodyn; 2006 Apr; 25(7):770-5. PubMed ID: 17016845
    [Abstract] [Full Text] [Related]

  • 31. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    van Venrooij GE, van Melick HH, Eckhardt MD, Boon TA.
    Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
    [Abstract] [Full Text] [Related]

  • 32. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
    Akino H, Maegawa M, Nagase K, Tanaka I, Nakai M, Ishida Y, Oyama N, Miwa Y, Yokoyama O.
    Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
    [Abstract] [Full Text] [Related]

  • 33. Does evaluation with the International Prostate Symptom Score predict the outcome of transurethral resection of the prostate?
    Hakenberg OW, Pinnock CB, Marshall VR.
    J Urol; 1997 Jul; 158(1):94-9. PubMed ID: 9186331
    [Abstract] [Full Text] [Related]

  • 34. How should patients with an overactive bladder manipulate their fluid intake?
    Hashim H, Abrams P.
    BJU Int; 2008 Jul; 102(1):62-6. PubMed ID: 18284414
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG, Kaplan SA, Kraus SR, Wang JT, Bavendam T, Guan Z.
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [Abstract] [Full Text] [Related]

  • 37. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
    Takao T, Tsujimura A, Kiuchi H, Takezawa K, Okuda H, Yamamoto K, Fukuhara S, Miyagawa Y, Nonomura N.
    Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Wada N, Watanabe M, Kita M, Matsumoto S, Kakizaki H.
    Neurourol Urodyn; 2012 Jun; 31(5):659-63. PubMed ID: 22488529
    [Abstract] [Full Text] [Related]

  • 40. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD, Liao CH, Chen YC, Kuo HC.
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.